DEFA14A 1 d572271ddefa14a.htm DEFA14A DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒                             Filed by a party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12

Mateon Therapeutics, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  1)  

Title of each class of securities to which transaction applies:

 

     

  2)  

Aggregate number of securities to which transaction applies:

 

     

  3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  4)  

Proposed maximum aggregate value of transaction:

 

     

  5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing:
  1)  

Amount previously paid:

 

     

  2)  

Form, Schedule or Registration Statement No.:

 

     

  3)  

Filing party:

 

     

  4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

 

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 20, 2018

 

 

 

LOGO     

         

 

Meeting Information            

 

     
          Meeting Type: Annual Meeting         

MATEON THERAPEUTICS, INC.        

       For holders as of: April 30, 2018      
         

 

Date:  June 20, 2018  

 

 

      Time: 10:00 AM PDT            

     
         

 

Location:   Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

 

     
LOGO       

     44 Montgomery Street

 

     36th Floor

     
      

 

     San Francisco, CA 94104

 

     
    

    

 

   
    

 

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 
    

 

See the reverse side of this notice  to  obtain proxy materials and  voting  instructions. 

 

 

 
      

LOGO


   

 

—  Before You Vote  —

 

    
        
        

How to Access the Proxy Materials

 

         

 

Proxy Materials Available to VIEW or RECEIVE:

     

 

 

 

 

 

 

 

 

    

 

       

1. Notice & Proxy Statement        2. Form 10-K         

 

How to View Online:

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

                               1) BY INTERNET:         www.proxyvote.com

                               2) BY TELEPHONE:     1-800-579-1639

                               3) BY E-MAIL*:             sendmaterial@proxyvote.com

 

*   If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 06, 2018 to facilitate timely delivery.

 

     
         
   

 

—  How To Vote  —

 

    
        

Please Choose One of the Following Voting Methods

 

LOGO     

               
     

Vote In Person: If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

     
       

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.

     

 

Internal Use

Only

 

         


  Voting items  
  The Board of Directors recommends that you vote FOR the following:

 

   LOGO
  1.    To elect five members to the Board
of Directors to hold office until
the 2019 annual meeting of
stockholders and until their
successors are duly elected and
qualified.
  
     Nominees           
 

 

01 DAVID J. CHAPLIN         02 SIMON C. PEDDER         03 DONALD R. REYNOLDS         04 BOBBY W. SANDAGE, JR.         05 WILLIAM D. SCHWIETERMAN

 

 

 

 

  
 

 

2.

  

 

To approve the amended and restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan, which includes an increase in the number of shares available for the grant of awards from 4,725,781 to 7,250,000 shares.

  
  3.    To approve an amendment to the Company’s Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 70,000,000 to 150,000,000.   

 

LOGO

 

 

4.

  

 

To ratify the appointment of OUM & CO. LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.

  
 

 

 

NOTE: If any other matters properly come before the annual meeting, or any adjournments thereof, the persons named in this proxy will vote on such matters in their discretion.

 

 

  
    
    
  LOGO             


    

 

Reserved for Broadridge Internal Control Information  

 

     
          
          
          
          
          
          

 

 

   Voting Instructions   
 
 

            THIS SPACE RESERVED FOR LANGUAGE PERTAINING TO

BANKS AND BROKERS

AS REQUIRED BY THE NEW YORK STOCK EXCHANGE

 

 

 

LOGO

    

 

Broadridge Internal Use Only

                THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE   

 

Job  #

Envelope  #

Sequence  #

#  of  # Sequence  #